Show simple item record

dc.contributor.authorMOVIA, DANIAen
dc.contributor.authorPRINA MELLO, ADRIELEen
dc.date.accessioned2017-01-13T14:32:23Z
dc.date.available2017-01-13T14:32:23Z
dc.date.issued2016en
dc.date.submitted2016en
dc.identifier.citationDekkers S, Oomen AG, Bleeker EA, Vandebriel RJ, Micheletti C, Cabellos J, Janer G, Fuentes N, Vázquez-Campos S, Borges T, Silva MJ, Prina-Mello A, Movia D, Nesslany F, Ribeiro AR, Leite PE, Groenewold M, Cassee FR, Sips AJ, Dijkzeul A, van Teunenbroek T, Wijnhoven SW, Towards a nanospecific approach for risk assessment., Regulatory toxicology and pharmacology : RTP, 80, 2016, 46-59en
dc.identifier.issn0273-2300en
dc.identifier.otherYen
dc.descriptionPUBLISHEDen
dc.description.abstractIn the current paper, a new strategy for risk assessment of nanomaterials is described, which builds upon previous project outcomes and is developed within the FP7 NANoREG project. NANoREG has the aim to develop, for the long term, new testing strategies adapted to a high number of nanomaterials where many factors can affect their environmental and health impact. In the proposed risk assessment strategy, approaches for (Quantitative) Structure Activity Relationships ((Q)SARs), grouping and read-across are integrated and expanded to guide the user how to prioritise those nanomaterial applications that may lead to high risks for human health. Furthermore, those aspects of exposure, kinetics and hazard assessment that are most likely to be influenced by the nanospecific properties of the material under assessment are identified. These aspects are summarised in six elements, which play a key role in the strategy: exposure potential, dissolution, nanomaterial transformation, accumulation, genotoxicity and immunotoxicity. With the current approach it is possible to identify those situations where the use of nanospecific grouping, read-across and (Q)SAR tools is likely to become feasible in the future, and to point towards the generation of the type of data that is needed for scientific justification, which may lead to regulatory acceptance of nanospecific applications of these tools.en
dc.description.sponsorshipThe research leading to these results has been partially funded by the European Union Seventh Framework Programme (FP7/2007–2013) under the project NANoREG (A common European approach to the regulatory testing of nanomaterials), grant agreement 310584. We would like to acknowledge the other T5.7 partners NIA, KI, CNR, and VSB for their valuable input during the discussions and the process of development of the risk assessment approach presented here. In addition, NANoREG partners from other tasks within WP5 as well as partners form other work packages are kindly acknowledged for their contribution to the discussion at the consortium meetings and other meetings and for the input to the manuscript. RIVM colleagues Cornelle Noorlander, Jaco Westra and Cindy Bekker are thanked for their contribution to the work and Fleur van Broekhuizen, Marja Pronk, Dick Sijm, Theo Vermeire and Jan Roels are acknowledged for feedback, critical reading and reviewing of the manuscript.en
dc.format.extent46-59en
dc.relation.ispartofseriesRegulatory toxicology and pharmacology : RTPen
dc.relation.ispartofseries80en
dc.rightsYen
dc.subjectNanomaterials; Risk assessment approach; Prioritisation; Grouping; Read-across; (Q)SARs; Testing strategyen
dc.subject.lcshNanomaterials; Risk assessment approach; Prioritisation; Grouping; Read-across; (Q)SARs; Testing strategyen
dc.titleTowards a nanospecific approach for risk assessment.en
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/dmoviaen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/prinameaen
dc.identifier.rssinternalid120418en
dc.identifier.doihttp://dx.doi.org/10.1016/j.yrtph.2016.05.037en
dc.rights.ecaccessrightsopenAccess
dc.identifier.orcid_id0000-0001-6412-8132en
dc.contributor.sponsorEuropean Union Framework Programme 7 (FP7)en
dc.contributor.sponsorGrantNumberFP7/2007 2013en
dc.identifier.urihttp://hdl.handle.net/2262/78739


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record